MX1 and dermatomyositis: For example, the skin lesions of patients with DM show type I IFN-induced recruitment of CXCR3+ lymphocytes, and robust expression of the type I IFN marker MxA has been demonstrated in both blood vessels and interstitial fibroblasts in the skin of patients with anti-MDA5+ DM (13–15).